S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
NASDAQ:JSPR

Jasper Therapeutics News Headlines

$11.39
-0.40 (-3.39 %)
(As of 10/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.70
$12.13
50-Day Range N/A
52-Week Range
$7.11
$18.88
Volume468,465 shs
Average Volume909,891 shs
Market Capitalization$142.38 million
P/E RatioN/A
Dividend YieldN/A
Beta0.08

Media Mentions By Week



Jasper Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JSPR
News Sentiment

0.57

0.34

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JSPR Articles
This Week

9

7

JSPR Articles
Average Week

Get Jasper Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter.

Jasper Therapeutics (NASDAQ JSPR) News Headlines Today

SourceHeadline
MarketBeat logoJasper Therapeutics Inc to Post Q3 2021 Earnings of ($0.17) Per Share, William Blair Forecasts (NASDAQ:JSPR)
americanbankingnews.com - October 25 at 1:21 AM
MarketBeat logoJasper Therapeutics (NASDAQ:JSPR) Coverage Initiated by Analysts at William Blair
americanbankingnews.com - October 21 at 7:51 AM
MarketBeat logoBMO Capital Markets Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR)
americanbankingnews.com - October 20 at 8:50 AM
finance.yahoo.com logoJasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?
finance.yahoo.com - October 16 at 12:10 AM
MarketBeat logoOppenheimer Comments on Jasper Therapeutics Inc's Q3 2021 Earnings (NASDAQ:JSPR)
americanbankingnews.com - October 15 at 7:06 AM
marketwatch.com logoJasper Therapeutics Shares Take Flight After Oppenheimer Endorsement >JSPR
marketwatch.com - October 15 at 4:05 AM
benzinga.com logoWhy Jasper Therapeutics Stock Is Falling Today
benzinga.com - October 14 at 6:04 PM
realmoney.thestreet.com logoJasper Therapeutics, Inc. (JSPR)
realmoney.thestreet.com - October 14 at 3:02 AM
benzinga.com logoMid-Afternoon Market Update: Nasdaq Jumps 100 Points; Jasper Therapeutics Shares Spike Higher
benzinga.com - October 13 at 5:01 PM
nasdaq.com logoJasper Therapeutics Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - October 13 at 12:01 PM
msn.com logoJasper Therapeutics' stock more than doubles after Oppenheimer analyst's bullish call
msn.com - October 13 at 12:01 PM
nasdaq.com logoJasper Therapeutics Spikes
nasdaq.com - October 13 at 12:01 PM
finance.yahoo.com logoJasper Therapeutics Stock Soars after Oppenheimer Calls it a Buy
finance.yahoo.com - October 13 at 12:01 PM
msn.com logoJSPR Stock: The Bullish Call That Has Biotech Play Jasper Therapeutics Rocketing 105% Today
msn.com - October 13 at 12:01 PM
msn.com logoWhy Jasper Therapeutics Stock Is Jumping Today
msn.com - October 13 at 12:01 PM
feeds.benzinga.com logoWhy Jasper Therapeutics Stock Is Soaring Today
feeds.benzinga.com - October 13 at 10:49 AM
MarketBeat logoOppenheimer Begins Coverage on Jasper Therapeutics (NASDAQ:JSPR)
americanbankingnews.com - October 12 at 8:14 PM
Get Jasper Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.